ZTZ240 is a KCNQ2 K+ channel activator which offers a new target to treat hyperexcitability disorders. References: Kornilov P, Peretz A, Attali B. Channel gating pore: a new therapeutic target. Cell Res. 2013 Sep;23(9):1067-8. doi: 10.1038/cr.2013.89. Epub 2013 Jul 9. PubMed PMID: 23835478; PubMed Central PMCID: PMC3760620.

纯度：≥98%

CAS：325457-98-5